FDA Issues Official Action Indicated Warning to Aurobindo Pharma’s US Formulation Unit, Signaling Compliance Concerns
The U.S. Food and Drug Administration has classified Aurobindo Pharma’s formulation manufacturing facility in the United States with an Official Action Indicated (OAI) designation, a…